Thrombosis Research in Advanced Disease (TRAD) Alliance
“A global approach to thrombosis research”
Graduated from Athens Medical School in 1983 and completed his medical training in internal medicine in 1990. During this time he developed an interest in the field of medical oncology receiving his first training next to professor D. Skarlos. In 1991 He was awarded a grant to study ‘Immunology and Cancer’ and commenced studies at the ICRF laboratories, RPMS Hammersmith, under Prof A. Epenetos. In 1994 he obtained a PhD from LondonUniversity on the application of radiolabeled monoclonal antibodies in the treatment of Head and neck Cancer.
He subsequently became a lecturer at St George’sHospitalMedicalSchool studying the application of allogeneic vaccines in Melanoma with Pof. A. Dalgleish. In 1999 he became Senior Lecturer in Medical Oncology at the PGMI of the University of Hull helping establish the Cancer services for HEYCCN and the new medical School of HYMS. He was promoted to Reader in 2011. He treats gastrointestinal cancers with a particular interest in the impact of thrombosis on these patients, melanoma and renal cell carcinoma.
His research interests include the targeting of cancer neo-vasculature and the haemostatic apparatus to interfere with cancer metastasis. He is the CI for the FRAGEM trial, NCRN director for HEYCCRN and a co-director of TRAD-Alliance with Dr Miriam Johnson and Dr Simon Noble.
To view other Team Members Biographies please click here.
